Sialic-acid binding of CD22 is required for inhibition of the BCR signal

被引：0
|
作者：
不详
机构：
来源：
IMMUNOBIOLOGY | 2004年 / 209卷 / 4-6期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [21] The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound
    Kelm, S
    Gerlach, J
    Brossmer, R
    Danzer, CP
    Nitschke, L
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (09): : 1207 - 1213
  • [22] Inhibition of the B cell by CD22: A requirement for Lyn
    Smith, KGC
    Tarlinton, DM
    Doody, GM
    Hibbs, ML
    Fearon, DT
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05): : 807 - 811
  • [23] Regulation of B cell functions by the sialic acid-bincing receptors Siglec-G and CD22
    Jellusova, Julia
    Nitschke, Lars
    FRONTIERS IN IMMUNOLOGY, 2012, 2
  • [24] CD22 is constitutively associated with IgM: CD22's ligand-binding domains contribute to, but are not necessary for, association
    Jin, L
    Wortis, HH
    GLYCOBIOLOGY, 2003, 13 (11) : 880 - 880
  • [25] Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis
    Zhang, M
    Varki, A
    GLYCOBIOLOGY, 2004, 14 (11) : 939 - 949
  • [26] Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction
    Oezgoer, Lamia
    Meyer, Sarah J.
    Korn, Marina
    Teroerde, Klara
    Nitschke, Lars
    JOURNAL OF IMMUNOLOGY, 2018, 201 (07): : 2107 - 2116
  • [27] Manipulation of CD22 signal transduction for the treatment of lymphoma.
    Tuscano, JM
    DeNardo, G
    Wun, T
    Tedder, TF
    Kehrl, JH
    BLOOD, 1999, 94 (10) : 93A - 93A
  • [28] AN AZIDOARYL THIOGLYCOSIDE OF SIALIC-ACID - A POTENTIAL PHOTOAFFINITY PROBE OF SIALIDASES AND SIALIC ACID-BINDING PROTEINS
    WARNER, TG
    LEE, LA
    CARBOHYDRATE RESEARCH, 1988, 176 (02) : 211 - 218
  • [29] Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
    Rillahan, Cory D.
    Macauley, Matthew S.
    Schwartz, Erik
    He, Yuan
    McBride, Ryan
    Arlian, Britni M.
    Rangarajan, Janani
    Fokin, Valery V.
    Paulson, James C.
    CHEMICAL SCIENCE, 2014, 5 (06) : 2398 - 2406
  • [30] CD22 Is Required for Protection against West Nile Virus Infection
    Ma, Daphne Y.
    Suthar, Mehul S.
    Kasahara, Shinji
    Gale, Michael, Jr.
    Clark, Edward A.
    JOURNAL OF VIROLOGY, 2013, 87 (06) : 3361 - 3375
12345